美國同意房地產公司 ADC 深 滬
等待開盤 11-08 09:30:00 美东时间
73.41
+0.890
+1.23%
華盛通- 最 高73.52
- 今 開72.88
- 成交量 76.89万股
- 最 低 72.835
- 昨 收 72.52
- 總市值 84.42亿
- 52周最高 77.852
- 市盈率 靜 41.26
- 換手率 0.00%
- 52周最低 65.023
- 委 比 1.18%
- 總股本 1.15亿
- 歷史最高 77.852
- 量 比 0.68
- 振 幅 0.94%
- 歷史最低 -9.926
- 每 手 1
- 風險率 2.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多NNN REIT's Earnings Outlook
NNN REIT (NYSE:NNN) is gearing up to announce its quarterly earnings on Tuesday...
11-04 02:01
Earnings Preview For Federal Realty Investment
Federal Realty Investment (NYSE:FRT) is preparing to release its quarterly earn...
10-31 00:02
直击国谈首日：阿斯利康、恒瑞等药企齐登场，涉精神类药物等品种，多数代表离场面带笑容
财联社10月30日讯（记者 武超 卢阿峰）今日，2025年国家医保目录现场谈判与商保创新药目录价格协商在北京正式拉开帷幕。今年的国谈在延续医保目录常规调整机制的...
10-30 16:11
创新药大幅回调，发生了什么？港股通创新药ETF(159570)跌超2.5%，盘中持续溢价！机构：阶段加速调整后机会凸显！创新药三大支柱是什么？
今日（10.30），大盘午后震荡回调，创新药再度走低，再创阶段新低。100%创新药含量的港股通创新药ETF（159570）回调2.52%，盘中成交额大幅放量，已...
10-30 14:55
2025国家医保谈判启动，新增商保创新药协商，港股创新药精选ETF(520690)回调超2%，盘中交投活跃
截至2025年10月30日13:37，恒生港股通创新药精选指数下跌2.08%。成分股方面涨跌互现，四环医药领涨2.74%，映恩生物-B上涨2.68...
10-30 13:42
诺诚健华新型ADC创新药ICP-B794完成首例患者给药
诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，公司自主研发的靶向B7-H3的新型ADC创新药ICP-B794完成首例患者给药。 I...
10-30 09:15
GSK rises on higher profit growth projected for 2025
GSK (GSK) is up ~7% in Wednesday trading after reporting Q3 results that beat on both lines and updating its earnings growth projection for 2025. The drugmaker now sees core earnings per share to incr...
10-29 22:25
映恩生物“回A”破局：双平台驱动ADC龙头价值重估，平台型药企迎来定价革命
半年前，映恩生物以 94.60 港元的发行价登陆港股主板，首日开盘即高开 91.33%，盘中最高涨幅超 130%，最终收涨 116.7%，一举打破 2022 年...
10-29 20:14
1410亿身家！“医药女王”钟慧娟携女登顶“中国女首富”！
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源 | 野马财经 作者 | 孙梦圆 赵普 刘钦文 “中...
10-29 18:57
超千亿市值百利天恒，资金“饥渴”下的创新药“生死时速”
10月26日，百利天恒（688506.SH）这份发布三季报，将这家明星药企推上了舆论风口。 冰火两重天——这或许是描述百利天恒2025年三季度业绩最恰当的词语...
10-29 17:37
公司簡介
公司名稱
|
美国同意房地产公司
|
行業分類
|
房地产开发
|
業務描述
|
Agree Realty Corp. is a real estate investment trust, which engages in the ownership, acquisition, development, and management of retail properties net leased to industry tenants. It focuses on the long-term, fee simple ownership of properties net leased to national and large regional retailers. The company was founded by Richard Agree in 1971 and is headquartered in Royal Oak, MI.
|
NNN REIT's Earnings Outlook
NNN REIT (NYSE:NNN) is gearing up to announce its quarterly earnings on Tuesday...
11-04 02:01
Earnings Preview For Federal Realty Investment
Federal Realty Investment (NYSE:FRT) is preparing to release its quarterly earn...
10-31 00:02
直击国谈首日：阿斯利康、恒瑞等药企齐登场，涉精神类药物等品种，多数代表离场面带笑容
财联社10月30日讯（记者 武超 卢阿峰）今日，2025年国家医保目录现场谈判与商保创新药目录价格协商在北京正式拉开帷幕。今年的国谈在延续医保目录常规调整机制的...
10-30 16:11
创新药大幅回调，发生了什么？港股通创新药ETF(159570)跌超2.5%，盘中持续溢价！机构：阶段加速调整后机会凸显！创新药三大支柱是什么？
今日（10.30），大盘午后震荡回调，创新药再度走低，再创阶段新低。100%创新药含量的港股通创新药ETF（159570）回调2.52%，盘中成交额大幅放量，已...
10-30 14:55
2025国家医保谈判启动，新增商保创新药协商，港股创新药精选ETF(520690)回调超2%，盘中交投活跃
截至2025年10月30日13:37，恒生港股通创新药精选指数下跌2.08%。成分股方面涨跌互现，四环医药领涨2.74%，映恩生物-B上涨2.68...
10-30 13:42
诺诚健华新型ADC创新药ICP-B794完成首例患者给药
诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，公司自主研发的靶向B7-H3的新型ADC创新药ICP-B794完成首例患者给药。 I...
10-30 09:15
GSK rises on higher profit growth projected for 2025
GSK (GSK) is up ~7% in Wednesday trading after reporting Q3 results that beat on both lines and updating its earnings growth projection for 2025. The drugmaker now sees core earnings per share to incr...
10-29 22:25
映恩生物“回A”破局：双平台驱动ADC龙头价值重估，平台型药企迎来定价革命
半年前，映恩生物以 94.60 港元的发行价登陆港股主板，首日开盘即高开 91.33%，盘中最高涨幅超 130%，最终收涨 116.7%，一举打破 2022 年...
10-29 20:14
1410亿身家！“医药女王”钟慧娟携女登顶“中国女首富”！
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源 | 野马财经 作者 | 孙梦圆 赵普 刘钦文 “中...
10-29 18:57
超千亿市值百利天恒，资金“饥渴”下的创新药“生死时速”
10月26日，百利天恒（688506.SH）这份发布三季报，将这家明星药企推上了舆论风口。 冰火两重天——这或许是描述百利天恒2025年三季度业绩最恰当的词语...
10-29 17:37
派息除權日
|
每股總股息
| 派息日期 |
2025-10-31
|
0.26
|
2025-11-14
|
2025-09-30
|
0.26
|
2025-10-14
|
2025-08-29
|
0.26
|
2025-09-15
|
2025-07-31
|
0.26
|
2025-08-14
|
2025-06-30
|
0.26
|
2025-07-15
|
2025-05-30
|
0.26
|
2025-06-13
|
2025-04-30
|
0.26
|
2025-05-14
|
2025-03-31
|
0.25
|
2025-04-14
|
2025-02-28
|
0.25
|
2025-03-14
|
2025-01-31
|
0.25
|
2025-02-14
|
2024-12-31
|
0.25
|
2025-01-15
|
2024-11-29
|
0.25
|
2024-12-13
|
2024-10-31
|
0.25
|
2024-11-14
|
2024-09-30
|
0.25
|
2024-10-15
|
2024-08-30
|
0.25
|
2024-09-16
|
2024-07-31
|
0.25
|
2024-08-14
|
2024-06-28
|
0.25
|
2024-07-15
|
2024-05-31
|
0.25
|
2024-06-14
|
2024-04-29
|
0.25
|
2024-05-14
|
2024-03-27
|
0.25
|
2024-04-12
|
2024-02-28
|
0.25
|
2024-03-14
|
2024-01-30
|
0.25
|
2024-02-14
|
2023-12-28
|
0.25
|
2024-01-16
|
2023-11-29
|
0.25
|
2023-12-14
|
2023-10-30
|
0.25
|
2023-11-14
|
2023-09-28
|
0.24
|
2023-10-13
|
2023-08-30
|
0.24
|
2023-09-14
|
2023-07-28
|
0.24
|
2023-08-14
|
2023-06-29
|
0.24
|
2023-07-14
|
2023-05-30
|
0.24
|
2023-06-14
|
2023-04-27
|
0.24
|
2023-05-12
|
2023-03-30
|
0.24
|
2023-04-14
|
2023-02-27
|
0.24
|
2023-03-14
|
2023-01-30
|
0.24
|
2023-02-14
|
2022-12-29
|
0.24
|
2023-01-13
|
2022-11-29
|
0.24
|
2022-12-14
|
2022-10-28
|
0.24
|
2022-11-14
|
2022-09-29
|
0.23
|
2022-10-14
|
2022-08-30
|
0.23
|
2022-09-14
|
2022-07-28
|
0.23
|
2022-08-12
|
2022-06-29
|
0.23
|
2022-07-14
|
2022-05-30
|
0.23
|
2022-06-14
|
2022-04-28
|
0.23
|
2022-05-13
|
2022-03-30
|
0.23
|
2022-04-14
|
2022-02-25
|
0.23
|
2022-03-14
|
2022-01-28
|
0.23
|
2022-02-14
|
2021-12-30
|
0.23
|
2022-01-14
|
2021-11-29
|
0.23
|
2021-12-14
|
2021-10-28
|
0.23
|
2021-11-12
|
2021-09-29
|
0.22
|
2021-10-14
|
2021-08-30
|
0.22
|
2021-09-14
|
2021-07-29
|
0.22
|
2021-08-13
|
2021-06-29
|
0.22
|
2021-07-14
|
2021-05-27
|
0.22
|
2021-06-11
|
2021-04-29
|
0.22
|
2021-05-14
|
2021-03-30
|
0.21
|
2021-04-14
|
2021-02-25
|
0.21
|
2021-03-12
|
2021-01-28
|
0.21
|
2021-02-12
|
2020-12-22
|
0.62
|
2021-01-06
|
2020-09-24
|
0.60
|
2020-10-09
|
2020-06-25
|
0.60
|
2020-07-10
|
2020-03-26
|
0.58
|
2020-04-09
|
2019-12-19
|
0.58
|
2020-01-03
|
2019-09-26
|
0.57
|
2019-10-11
|
2019-06-27
|
0.57
|
2019-07-12
|
2019-03-28
|
0.56
|
2019-04-12
|
2018-12-20
|
0.56
|
2019-01-04
|
2018-09-27
|
0.54
|
2018-10-12
|
2018-06-28
|
0.54
|
2018-07-13
|
2018-05-02
|
0.001
|
2018-05-02
|
2018-03-28
|
0.52
|
2018-04-13
|
2017-12-19
|
0.52
|
2018-01-03
|
2017-09-28
|
0.50
|
2017-10-13
|
2017-06-28
|
0.50
|
2017-07-14
|
2017-03-29
|
0.50
|
2017-04-14
|
2016-12-21
|
0.50
|
2017-01-03
|
2016-09-28
|
0.48
|
2016-10-14
|
2016-06-28
|
0.48
|
2016-07-15
|
2016-03-29
|
0.47
|
2016-04-15
|
2015-12-18
|
0.47
|
2016-01-05
|
2015-09-28
|
0.47
|
2015-10-13
|
2015-06-26
|
0.47
|
2015-07-14
|
2015-03-27
|
0.45
|
2015-04-14
|
2014-12-19
|
0.45
|
2015-01-06
|
2014-09-26
|
0.43
|
2014-10-14
|
2014-06-26
|
0.43
|
2014-07-08
|
2014-03-27
|
0.43
|
2014-04-08
|
2013-12-18
|
0.41
|
2014-01-03
|
2013-09-26
|
0.41
|
2013-10-08
|
2013-06-26
|
0.41
|
2013-07-09
|
2013-03-26
|
0.41
|
2013-04-09
|
2012-12-13
|
0.40
|
2013-01-02
|
2012-09-26
|
0.40
|
2012-10-09
|
2012-06-27
|
0.40
|
2012-07-10
|
2012-03-28
|
0.40
|
2012-04-10
|
2011-12-15
|
0.40
|
2012-01-03
|
2011-09-28
|
0.40
|
2011-10-11
|
2011-06-28
|
0.40
|
2011-07-12
|
2011-03-29
|
0.40
|
2011-04-12
|
2010-12-16
|
0.51
|
2011-01-04
|
2010-09-28
|
0.51
|
2010-10-13
|
2010-06-28
|
0.51
|
2010-07-13
|
2010-03-29
|
0.51
|
2010-04-13
|
2009-12-17
|
0.51
|
2010-01-05
|
2009-09-28
|
0.51
|
2009-10-15
|
2009-06-26
|
0.50
|
2009-07-14
|
2009-03-27
|
0.50
|
2009-04-14
|
2008-12-18
|
0.50
|
2009-01-06
|
2008-09-26
|
0.50
|
2008-10-14
|
2008-06-26
|
0.50
|
2008-07-15
|
2008-03-27
|
0.50
|
2008-04-15
|
2007-12-19
|
0.50
|
2008-01-04
|
2007-09-26
|
0.49
|
2007-10-11
|
2007-06-27
|
0.49
|
2007-07-12
|
2007-03-28
|
0.49
|
2007-04-12
|
2006-12-20
|
0.49
|
2007-01-04
|
2006-09-27
|
0.49
|
2006-10-12
|
2006-06-28
|
0.49
|
2006-07-13
|
2006-03-29
|
0.49
|
2006-04-13
|
2005-12-21
|
0.49
|
2006-01-05
|
2005-09-28
|
0.49
|
2005-10-13
|
2005-06-28
|
0.49
|
2005-07-14
|
2005-03-29
|
0.49
|
2005-04-14
|
2004-12-21
|
0.49
|
2005-01-06
|
2004-09-28
|
0.49
|
2004-10-12
|
2004-06-28
|
0.49
|
2004-07-13
|
2004-03-29
|
0.49
|
2004-04-15
|
2003-12-18
|
0.49
|
2004-01-06
|
2003-09-26
|
0.49
|
2003-10-16
|
2003-06-26
|
0.49
|
2003-07-15
|
2003-03-26
|
0.48
|
2003-04-15
|
2002-12-18
|
0.46
|
2003-01-06
|
2002-09-25
|
0.46
|
2002-10-10
|
2002-06-26
|
0.46
|
2002-07-11
|
2002-03-26
|
0.46
|
2002-04-11
|
2001-12-19
|
0.46
|
2002-01-04
|
2001-09-26
|
0.46
|
2001-10-11
|
2001-06-27
|
0.46
|
2001-07-12
|
2001-03-28
|
0.46
|
2001-04-12
|
2000-12-20
|
0.46
|
2001-01-04
|
2000-09-27
|
0.46
|
2000-10-12
|
2000-06-28
|
0.46
|
2000-07-13
|
2000-03-29
|
0.46
|
2000-04-13
|
1999-12-21
|
0.46
|
2000-01-06
|
1999-09-28
|
0.46
|
1999-10-14
|
1999-06-28
|
0.46
|
1999-07-15
|
1999-03-29
|
0.46
|
1999-04-15
|
1998-12-21
|
0.46
|
1999-01-07
|
1998-09-28
|
0.46
|
1998-10-15
|
1998-06-26
|
0.46
|
1998-07-16
|
1998-03-27
|
0.46
|
1998-04-16
|
1997-12-19
|
0.46
|
1998-01-06
|
1997-09-26
|
0.46
|
1997-10-16
|
1997-06-26
|
0.45
|
1997-07-17
|
1997-03-20
|
0.45
|
1997-04-16
|
1996-12-19
|
0.45
|
1997-01-06
|
1996-09-26
|
0.45
|
1996-10-17
|
1996-06-26
|
0.45
|
1996-07-18
|
1996-03-27
|
0.45
|
1996-04-18
|
1995-12-20
|
0.45
|
1996-01-04
|
1995-09-27
|
0.45
|
1995-10-12
|
1995-06-28
|
0.45
|
1995-07-13
|
1995-03-27
|
0.45
|
1995-04-13
|
1994-12-23
|
0.45
|
1995-01-13
|
1994-09-26
|
0.45
|
1994-10-14
|
1994-06-20
|
0.35
|
1994-07-05
|
